Patients with elevated WBC/Hb ratios may require higher levels of care, expedited diagnostics, or timely anti-inflammatory treatment and correction of anemia using transfusions or erythropoiesis-stimulating agents. This evidence concerns the gene GSTM1 and anemia (phenotype).